Edesa Biotech Management

How experienced are the management team and are they aligned to shareholders interests?

3.3yrs

Average management tenure


CEO

Par Nijhawan (51 yo)

3.25yrs

Tenure

US$1,319,299

Compensation

Dr. Pardeep Nijhawan, also known as Par, M.D., FRCPC, AGAF serves as Chief Executive Officer, Company secretary and Director at Edesa Biotech, Inc. since June 7, 2019 and having previously founded and led...


CEO Compensation Analysis

Par Nijhawan's Compensation vs Edesa Biotech Earnings
How has Par Nijhawan's remuneration changed compared to Edesa Biotech's earnings?
DateTotal Comp.SalaryCompany Earnings
Jun 30 2022n/an/a

-US$18m

Mar 31 2022n/an/a

-US$17m

Dec 31 2021n/an/a

-US$15m

Sep 30 2021US$1mUS$315k

-US$13m

Jun 30 2021n/an/a

-US$12m

Mar 31 2021n/an/a

-US$9m

Dec 31 2020n/an/a

-US$8m

Sep 30 2020US$411kUS$300k

-US$6m

Jun 30 2020n/an/a

-US$5m

Mar 31 2020n/an/a

-US$5m

Dec 31 2019n/an/a

-US$4m

Sep 30 2019US$165kUS$105k

-US$3m

Jun 30 2019n/an/a

-US$3m

Mar 31 2019n/an/a

-US$2m

Dec 31 2018US$61kUS$27k

-US$2m

Compensation vs Market: Par's total compensation ($USD1.32M) is above average for companies of similar size in the US market ($USD787.63K).

Compensation vs Earnings: Par's compensation has increased whilst the company is unprofitable.


Leadership Team

Experienced Management: EDSA's management team is considered experienced (3.3 years average tenure).


Board Members

Experienced Board: EDSA's board of directors are considered experienced (3.3 years average tenure).